NANETS Webinar Series:
Surgical Management of Pancreatic Neuroendocrine Tumors
in collaboration with the Society of Surgical Oncology 

Part I: May 18, 2020 - Members of NANETS can watch the recording of part-one by logging in here
Part II: June 18, 2020, 7:00 pm – 8:00 pm ET

Presenters:
James Howe, MD, Carver College of Medicine, University of Iowa
Rodney Pommier, MD, Oregon Health & Science University Hospital

Moderators:
Jennifer Eads, MD, University of Pennsylvania (May 18)
Jennifer Chan, MD, Dana Farber Cancer Institute (June 18)

2 AMA PRA Category 1 Credits™, MOC and nursing continued education credits (must attend both webinars to obtain credits)

NANETS, in collaboration with the Society of Surgical Oncology (SSO), presents a two-part webinar on the published Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors (pNETs). Join surgical pNETs consensus paper authors, James Howe, MD and Rodney Pommier, MD for part I on May 18 and part II on June 18.

Due to the rarity of these tumors, institutional experiences may be quite variable, and clinicians must rely upon their judgment and discussions in multidisciplinary tumor boards to best serve their patients. During this webinar, we will identify several areas related to the surgical management of patients with pNETs and will explore options for dealing with important clinical questions.

Consensus Paper Overview

Treatment options for patients with PNETs depend upon the anatomic location of the tumor within the gland, size, multifocality, the extent of disease (localized or metastatic), grade, involvement of adjacent structures, and patient comorbidities. Some management issues in patients with PNETs are clearer than others, such as the appropriate surgical procedures for tumors in different parts of the gland. Many others are not clear at all, and evidence for the correct approaches for specific patient situations is lacking. We have identified a number of controversial areas related to the surgical management of patients with PNETs and assembled a group of expert clinicians to explore the literature to present options for dealing with these important clinical questions.

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Members of NANETS can watch the recording of part-one by logging in here

Registration - Part 2 - June 18

Reminder: You must attend both webinars to obtain accreditation.



NANETS Webinar Series:
Peptide Receptor Radionuclide Therapy (PRRT)
: Background, Published Results, Patient Selection Details, Sequencing of Therapy, Future Directions

July 23, 2020 - Date Subject to Change

Presenters:
Jonathan Strosberg, MD, Moffitt Cancer Center
Lisa Bodei, MD, Memorial Sloan Kettering Cancer Center

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™, MOC and nursing continued education credits

Registration - to be posted four weeks in advance 

NANETS Webinar Series:
Medical Management: Lung NETs

November 18, 2020 - Date Subject to Change

Presenters:
Sukhmani Padda, MD, Stanford University
Robert Ramirez, MD, Ochsner Medical Center

Moderator:
Emily Bergland, MD, University of California, San Francisco School of Medicine

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration - to be posted four weeks in advance 

NANETS Webinar Series:
Hereditary Syndromes with NETs: MEN1/2, VHL Pheochromocytoma /Paraganglioma

September 16, 2020 - Date Subject to Change

Presenters:
Lauren Fishbein, MD, PhD, University of Colorado School of Medicine
Mark Lewis, MD, Intermountain Healthcare

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 2 AMA PRA Category 1 Credits™, MOC and nursing continued education credits 

Registration - to be posted four weeks in advance